These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20081743)

  • 21. Heart valve tissue engineering.
    Vesely I
    Circ Res; 2005 Oct; 97(8):743-55. PubMed ID: 16224074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stented within a stentless aortic valve. A simple surgical solution for the replacement of a stentless aortic bioprosthesis.
    Panagiotou M; Kogerakis N; Crockett JR; Economidou S
    Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):7-8. PubMed ID: 19805504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory responses of tissue-engineered xenografts in a clinical scenario.
    Mathapati S; Verma RS; Cherian KM; Guhathakurta S
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):360-5. PubMed ID: 21183503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitral valve re-replacement in a patient with osteogenesis imperfecta.
    Pfannmueller B; Borger MA; Battellini RR; Mohr FW
    Thorac Cardiovasc Surg; 2010 Dec; 58(8):486-8. PubMed ID: 21110273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological heart valves.
    Ciubotaru A; Cebotari S; Tudorache I; Beckmann E; Hilfiker A; Haverich A
    Biomed Tech (Berl); 2013 Oct; 58(5):389-97. PubMed ID: 24101369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticalcification strategies to increase bioprosthetic valve durability.
    Thiene G; Valente M
    J Heart Valve Dis; 2011 Jan; 20(1):37-44. PubMed ID: 21404896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.
    Sewell-Loftin MK; Chun YW; Khademhosseini A; Merryman WD
    J Cardiovasc Transl Res; 2011 Oct; 4(5):658-71. PubMed ID: 21751069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on decellularized porcine aortic valve/poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) hybrid heart valve in sheep model.
    Wu S; Liu YL; Cui B; Qu XH; Chen GQ
    Artif Organs; 2007 Sep; 31(9):689-97. PubMed ID: 17725696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation after bioprosthetic aortic valve replacement.
    Nowell J; Jahangiri M
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1201-2; author reply 1202. PubMed ID: 20951265
    [No Abstract]   [Full Text] [Related]  

  • 33. Transcatheter valve-in-valve implantation for the treatment of stentless aortic valve dysfunction.
    Rodés-Cabau J; Dumont E; Doyle D; Lemieux J
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):246-8. PubMed ID: 19783014
    [No Abstract]   [Full Text] [Related]  

  • 34. [Heart valve and myocardial tissue engineering].
    Cebotari S; Tudorache I; Schilling T; Haverich A
    Herz; 2010 Aug; 35(5):334-41. PubMed ID: 20631970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explantation of a 44-year-old Starr-Edwards mitral valve for delayed hemolysis.
    Fernandez J; Farivar RS
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):e35-6. PubMed ID: 20117803
    [No Abstract]   [Full Text] [Related]  

  • 36. "In vivo tissue-engineered" valved conduit with designed molds and laser processed scaffold.
    Hayashida K; Kanda K; Oie T; Okamoto Y; Sakai O; Watanabe T; Ishibashi-Ueda H; Onoyama M; Tajikawa T; Ohba K; Yaku H; Nakayama Y
    J Cardiovasc Nurs; 2008; 23(1):61-4. PubMed ID: 18158510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular grafts and valves that animate, made from decellularized biologically-engineered tissue tubes.
    Syedain ZH; Maciver R; Tranquillo RT
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):577-585. PubMed ID: 32964902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. eComment: Freedom Solo stentless aortic bioprosthesis and postoperative thrombocytopenia--interpretation of available data and clinical consequences for surgeons.
    Yerebakan C; Westphal B; Steinhoff G; Liebold A
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):73-4. PubMed ID: 19122155
    [No Abstract]   [Full Text] [Related]  

  • 40. State of the Art: Tissue Engineering in Congenital Heart Surgery.
    Boyd R; Parisi F; Kalfa D
    Semin Thorac Cardiovasc Surg; 2019; 31(4):807-817. PubMed ID: 31176798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.